Featured news

5 Quick Questions with Katarina Alenäs

Katarina Alenäs, SVP Chromatography Nanologica AB Who is Katarina Alenäs? I have a M.Sc. in Chemical Engineering and a B.Sc. in Pharmaceutical Sciences and have spent most of my professional career within chromatography which is an area very close to my heart. Before joining Nanologica, I was the Country General Manager at Agilent Technologies Sweden, and before that I have been Product Manager Shimadzu HPLC/LCMS and I started my career as a Development Engineer of

Read more »

MVIC Inhalation Symposium

October 12-13, Nanologica will take part of the MVIC Inhalation Symposium in Lund where Nanologica’s Senior Scientist Dr Georgia Pilkington will give a speach on Evaluation of Nanoporous Particles as a Delivery Vehicle for Inhaled Drugs. MVIC Symposium in Lund 12-13 October 2022

Read more »

Nanologica Raises MSEK 79,8 in Rights Issue

 NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, HONG KONG, NEW ZEALAND, SWITZERLAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR PUBLICATION OF THIS PRESS RELEASE WOULD BE UNLAWFUL OR REQUIRE ADDITIONAL REGISTRATION OR OTHER MEASURES.  Nanologica AB (publ) (”Nanologica” or the “Company”) today announces the outcome of the new shares issue with preferential rights for Nanologica’s existing shareholders (the

Read more »

Nanologica Receives Order for Silica for Preparative Chromatography from US Customer

Nanologica AB (publ) has received an order for the company’s silica for preparative chromatography to a value of approximately TSEK 230. The order comes from a customer in the North American market. During 2022, Nanologica has completed the up-scaling to large-scale production of the company’s commercial silica for preparative chromatography, NLAB Saga®.  This order is a direct consequence of the company now being able to deliver the volumes of silica required for customers to be

Read more »

CEO Comment in Connection with the Preferential Rights Issue 2022

In 2022, Nanologica has taken important steps forward in the chromatography business area. We have scaled up the production of our commercial silica for preparative chromatography, NLAB Saga®, to tonal scale, and we have sold the first products in preparative chromatography, as well as taken orders for NLAB Saga® for production-scale evaluation from one of the world’s largest insulin manufacturers. The fact that we now have products from our large-scale production means that we can

Read more »